Post-Marketing Surveillance of the Safety, Tolerability and Efficacy of Ezetimibe Among Filipino Patients.

Trial Profile

Post-Marketing Surveillance of the Safety, Tolerability and Efficacy of Ezetimibe Among Filipino Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Jun 2014

At a glance

  • Drugs Ezetimibe; HMG-CoA reductase inhibitors
  • Indications Hypercholesterolaemia
  • Focus Adverse reactions
  • Sponsors Schering-Plough
  • Most Recent Events

    • 15 Jul 2009 Actual patient number (4105) added as reported by ClinicalTrials.gov.
    • 29 Sep 2008 Actual end date (Mar 2007) added as reported by ClinicalTrials.gov.
    • 29 Sep 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top